{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T10:30:26Z","timestamp":1761561026267},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2006,1,11]],"date-time":"2006-01-11T00:00:00Z","timestamp":1136937600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Gastroenterol"],"published-print":{"date-parts":[[2006,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Gastrointestinal bleeding is a common problem and its most common etiology is peptic ulcer disease. Ulcer rebleeding is considered a perilous complication for patients. To reduce the rate of rebleeding and to fasten the improvement of patients' general conditions, most emergency departments in Iran use H2-blockers before endoscopic procedures (i.e. intravenous omeprazole is not available in Iran). The aim of this study was to compare therapeutic effects of oral omeprazole and intravenous cimetidine on reducing rebleeding rates, duration of hospitalization, and the need for blood transfusion in duodenal ulcer patients.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>In this clinical trial, 80 patients with upper gastrointestinal bleeding due to duodenal peptic ulcer and endoscopic evidence of rebleeding referring to emergency departments of Imam and Sina hospitals in Tabriz, Iran were randomly assigned to two equal groups; one was treated with intravenous cimetidine 800 mg per day and the other, with 40 mg oral omeprazole per day.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>No statistically significant difference was found between cimetidine and omeprazole groups in regards to sex, age, alcohol consumption, cigarette smoking, NSAID consumption, endoscopic evidence of rebleeding, mean hemoglobin and mean BUN levels on admission, duration of hospitalization and the mean time of rebleeding. However, the need for blood transfusion was much lower in omeprazole than in cimetidine group (mean: 1.68 versus 3.58 units, respectively; p &lt; 0.003). Moreover, rebleeding rate was significantly lower in omeprazole group (15%) than in cimetidine group (50%) (p &lt; 0.001).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>This study demonstrated that oral omeprazole significantly excels intravenous cimetidine in reducing the need for blood transfusion and lowering rebleeding rates in patients with upper gastrointestinal bleeding. Though not statistically significant (p = 0.074), shorter periods of hospitalization were found for omeprazole group which merits consideration for cost minimization.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/1471-230x-6-2","type":"journal-article","created":{"date-parts":[[2006,1,23]],"date-time":"2006-01-23T12:36:30Z","timestamp":1138019790000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["A comparison of oral omeprazole and intravenous cimetidine in reducing complications of duodenal peptic ulcer"],"prefix":"10.1186","volume":"6","author":[{"given":"Manouchehr","family":"Khoshbaten","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ebrahim","family":"Fattahi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nosratollah","family":"Naderi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Farzaneh","family":"Khaleghian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammadreza","family":"Rezailashkajani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2006,1,11]]},"reference":[{"key":"146_CR1","first-page":"252","volume-title":"Gastrointestinal bleeding. Textbook of Harrison's principles of Internal Medicine","author":"L Loren","year":"2001","unstructured":"Loren L: Gastrointestinal bleeding. Textbook of Harrison's principles of Internal Medicine. 2001, McGraw hill, USA, 1: 252-15","edition":"15"},{"issue":"3","key":"146_CR2","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1007\/s002689910046","volume":"24","author":"C Ohmann","year":"2000","unstructured":"Ohmann C, Imhof M, Roher HD: Trends in peptic ulcer bleeding and surgical treatment. World J Surg. 2000, 24 (3): 284-93. 10.1007\/s002689910046.","journal-title":"World J Surg"},{"key":"146_CR3","first-page":"727","volume-title":"Hepatogastroenterology","author":"MA Shafi","year":"1999","unstructured":"Shafi MA, Fleischer DE: Risk factors of acute ulcer bleeding. Hepatogastroenterology. 1999, 727-31."},{"key":"146_CR4","doi-asserted-by":"crossref","unstructured":"Lin HJ, Lo WC, Lee FY, Perng CL, Tsenng GY: A prospective randomized comparative trial showing that Omeprazole prevents rebleeding in patients with bleeding peptic ulcer after successful endoscopic therapy. Arch Intern Med. 158 (2): 54-58. 1998 Jan; 12","DOI":"10.1001\/archinte.158.1.54"},{"issue":"2","key":"146_CR5","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1097\/00004836-199803000-00005","volume":"26","author":"HJ Lin","year":"1998","unstructured":"Lin HJ, Tseng GY, Lo WC, Lee FY, Perng CL, Chang FY, Lee SD: Predictive factors for rebleeding in patients with peptic ulcer bleeding after multipolar electrocoagulation: A retrospective analysis. J Clin Gastroenterol. 1998, 26 (2): 113-6. 10.1097\/00004836-199803000-00005.","journal-title":"J Clin Gastroenterol"},{"issue":"11","key":"146_CR6","doi-asserted-by":"publisher","first-page":"3184","DOI":"10.1111\/j.1572-0241.1999.01516.x","volume":"94","author":"HJ Lin","year":"1999","unstructured":"Lin HJ, Tseng GY, Hsieh YH, Perng CL, Lee FY, Chang FY, Lee SD: Will Helicobacter pylori affect short-term rebleeding rate in peptic ulcer bleeding patients after successful endoscopic therapy?. Am J Gastroenterol. 1999, 94 (11): 3184-8. 10.1111\/j.1572-0241.1999.01516.x.","journal-title":"Am J Gastroenterol"},{"issue":"8571","key":"146_CR7","doi-asserted-by":"publisher","first-page":"1292","DOI":"10.1016\/S0140-6736(87)91191-3","volume":"2","author":"J Panes","year":"1987","unstructured":"Panes J, Viver J, Forne M, Garcia-Olivares E, Marco C, Garau J: Controlled trial of endoscopic sclerosis in bleeding peptic ulcers. Lancet. 1987, 2 (8571): 1292-4. 10.1016\/S0140-6736(87)91191-3.","journal-title":"Lancet"},{"key":"146_CR8","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/0016-5085(92)91793-4","volume":"102","author":"DJ Cook","year":"1992","unstructured":"Cook DJ, Guyatt GH, Salena BJ, Laine LA: Endoscopic Therapy for acute nonvariceal upper gastrointestinal hemorrhage: A metaanalysis. Gastroenterology. 1992, 102: 139-48.","journal-title":"Gastroenterology"},{"key":"146_CR9","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/S0039-6109(05)70424-2","volume":"76","author":"GC Jiranek","year":"1996","unstructured":"Jiranek GC, Kozarek RA: A cost effective approach to the patient with peptic ulcer bleeding. Surg Clin North AM. 1996, 76: 83-103. 10.1016\/S0039-6109(05)70424-2.","journal-title":"Surg Clin North AM"},{"key":"146_CR10","doi-asserted-by":"publisher","first-page":"1565","DOI":"10.1046\/j.1365-2036.1999.00623.x","volume":"13","author":"AN Barkun","year":"1999","unstructured":"Barkun AN, Gookerman AW, Ploude V, Fedoroak RN: Acid suppression in non-variceal acute upper gastrointestinal bleeding. Aliment Pharmacol Ther. 1999, 13: 1565-84. 10.1046\/j.1365-2036.1999.00623.x.","journal-title":"Aliment Pharmacol Ther"},{"issue":"12","key":"146_CR11","first-page":"1465","volume":"B","author":"AN Barkun","year":"1999","unstructured":"Barkun AN, Cockeram AW, Plourede V, Fedoyak RN: Acid suppression in non-variceal acute upper gastrointestinal bleeding. Aliment Pharmacol Ther. 1999, B (12): 1465-84.","journal-title":"Aliment Pharmacol Ther"},{"key":"146_CR12","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1136\/bmj.38356.641134.8F","volume":"330","author":"GI Leontiadis","year":"2005","unstructured":"Leontiadis GI, Sharma VK, Howden CW: Systematic review and meta-analysis of proton pump inhibitor therapy in peptic ulcer bleeding. BMJ. 2005, 330: 568-10.1136\/bmj.38356.641134.8F.","journal-title":"BMJ"},{"issue":"2","key":"146_CR13","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1046\/j.1440-1746.2000.02055.x","volume":"15","author":"Y Li","year":"2000","unstructured":"Li Y, Sha W, Nie Y, Wu H, She Q, Dai S, Jia L, Yu W: Effect of intragastric pH on control of peptic ulcer bleeding. J Gastroenterology Hepatol. 2000, 15 (2): 148-54. 10.1046\/j.1440-1746.2000.02055.x.","journal-title":"J Gastroenterology Hepatol"},{"key":"146_CR14","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1056\/NEJM199704103361503","volume":"336","author":"MS Khuroo","year":"1997","unstructured":"Khuroo MS, Yattoo GN, Javid G, Khan BA, Shah AA, Gulzar GM, Sodi JS: A comparison of Omeprazole and placebo for bleeding peptic ulcer. N Engl J Med. 1997, 336: 1054-8. 10.1056\/NEJM199704103361503.","journal-title":"N Engl J Med"},{"issue":"5","key":"146_CR15","first-page":"467","volume":"7","author":"S Erikson","year":"1995","unstructured":"Erikson S, Langstrom G, Rikher L, Carlson R, Naesda J: Omeprazole and H2 receptor antagonists in the acute treatment of duodenal ulcer, gastric ulcer and reflux esophagitis: A meta-analysis. Eur J Gastroenterol Hepatol. 1995, 7 (5): 467-75.","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"7","key":"146_CR16","doi-asserted-by":"publisher","first-page":"1736","DOI":"10.1111\/j.1572-0241.2002.05780.x","volume":"97","author":"HK Jung","year":"2002","unstructured":"Jung HK, Son HY, Jung SA, Yi SY, Yoo K, Kim DY, Moon IH, Lee HC: Comparison of oral omeprazole and endoscopic ethanol injection therapy for prevention of recurrent bleeding from peptic ulcers with nonbleeding visible vessels or fresh adherent clots. Am J Gastroenterol. 2002, 97 (7): 1736-40. 10.1111\/j.1572-0241.2002.05780.x.","journal-title":"Am J Gastroenterol"},{"issue":"1","key":"146_CR17","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1097\/00004836-200001000-00004","volume":"30","author":"M Bustamante","year":"1999","unstructured":"Bustamante M, Stollman N: The efficiency of proton pump inhibitors in acute ulcer bleeding: A quqlitqtive review. J Clin Gastrol. 1999, 30 (1): 7-13. 10.1097\/00004836-200001000-00004.","journal-title":"J Clin Gastrol"},{"key":"146_CR18","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1056\/NEJM200008033430501","volume":"343","author":"JY Lau","year":"2000","unstructured":"Lau JY, Sung JJ, Lee KK, Yung MY, Wong SK, Wu JC, Chan FK, Ng EK, You JH, Lee CW, Chan AC, Chung SC: Effect of intravenous omeprazole on recurrent bleeding after endoscopic treatment of bleeding peptic ulcers. New England Journal of Medicine. 2000, 343: 310-16. 10.1056\/NEJM200008033430501.","journal-title":"New England Journal of Medicine"},{"issue":"4","key":"146_CR19","doi-asserted-by":"publisher","first-page":"320","DOI":"10.3109\/00365529709007679","volume":"32","author":"OB Schaffalitzky de Muckadell","year":"1997","unstructured":"Schaffalitzky de Muckadell OB, Havelund T, Harling H, Boesby S, Snel P, Vreeburg EM, Eriksson S, Fernstrom P, Hasselgren G: Effect of Omeprazole on the outcome of endoscopically treated bleeding peptic ulcers: A randomized double blind placebo controlled multicenter study. Scand J Gastroenterol. 1997, 32 (4): 320-7.","journal-title":"Scand J Gastroenterol"},{"key":"146_CR20","doi-asserted-by":"publisher","first-page":"16","DOI":"10.3109\/00365529609094726","volume":"218","author":"J Kolkman","year":"1996","unstructured":"Kolkman J, Meuwissen SG: A review on treatment of bleeding peptic ulcer: A collaborative task of gastroenterologist and surgeon. Scand J Gastroenterol suppl. 1996, 218: 16-25.","journal-title":"Scand J Gastroenterol suppl"},{"issue":"4","key":"146_CR21","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1007\/BF02087411","volume":"39","author":"B Katschinski","year":"1994","unstructured":"Katschinski B, Logan R, Davies J, Faulkner G, Pearson J, Langman M: Prognostic factors in upper gastrointestinal bleeding. Dis Dig Sci. 1994, 39 (4): 706-12. 10.1007\/BF02087411.","journal-title":"Dis Dig Sci"},{"issue":"6","key":"146_CR22","first-page":"924","volume":"92","author":"DA Peure","year":"1997","unstructured":"Peure DA, Lanza FL, Gastout CJ, Foutch PG: The American college of Gastroenterology bleeding registry: Preliminary findings. AM J Gastroenterol. 1997, 92 (6): 924-8.","journal-title":"AM J Gastroenterol"},{"key":"146_CR23","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1046\/j.1365-2036.2003.01416.x","volume":"17","author":"MJ Kaviani","year":"2003","unstructured":"Kaviani MJ, Hashemi MR, Kazemifar AR, Roozitalab S, Mostaghni AA, Merat S, Alizadeh-Naini M, Yarmohammadi H: Effect of oral Omeprazole in reducing rebleeding in bleeding peptic ulcers. Aliment Pharmacol Ther. 2003, 17: 211-216. 10.1046\/j.1365-2036.2003.01416.x.","journal-title":"Aliment Pharmacol Ther"},{"issue":"1","key":"146_CR24","first-page":"42","volume":"92","author":"WN Segal","year":"1997","unstructured":"Segal WN, Cello JP: Hemorrhage in the upper gastrointestinal tract in the older patients. AM J Gastroenterol. 1997, 92 (1): 42-46.","journal-title":"AM J Gastroenterol"}],"container-title":["BMC Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-230X-6-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-230X-6-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-230X-6-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-230X-6-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,31]],"date-time":"2021-08-31T21:49:01Z","timestamp":1630446541000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcgastroenterol.biomedcentral.com\/articles\/10.1186\/1471-230X-6-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,1,11]]},"references-count":24,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2006,12]]}},"alternative-id":["146"],"URL":"https:\/\/doi.org\/10.1186\/1471-230x-6-2","relation":{},"ISSN":["1471-230X"],"issn-type":[{"value":"1471-230X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,1,11]]},"assertion":[{"value":"2 January 2005","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 January 2006","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 January 2006","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"2"}}